Amcor is a global leader in packaging solutions for food, beverage, and healthcare products.
The company's identity is defined by its extensive scale, innovative sustainability efforts, and deep customer relationships across a stable but competitive industry.
Updated: February 27, 2026, 16:00 EST
Based on a comprehensive analysis, Amcor (AMCR) presents a conflicting investment picture that skews slightly negative.
Technically, the stock shows encouraging momentum with strong recent outperformance and lower volatility, suggesting market favor. However, fundamental weaknesses are a significant concern, with declining revenue, contracting profit margins, and poor operational efficiency indicating underlying business pressures. This fundamental softness is particularly troubling when viewed against its premium valuation, highlighted by high P/E ratios and a negative PEG ratio, which suggests the current price may not be justified by its growth prospects.
Therefore, despite the positive technicals indicating short-term momentum, the confluence of poor fundamentals and a stretched valuation presents substantial risk. A buy recommendation is not warranted at this time; investors should wait for clearer signs of improved profitability and operational execution before considering a position.
*This is not investment advice, for reference only.*
Of course. Here is a 12-month outlook for Amcor (AMCR) based on your analysis.
12-Month Outlook for Amcor (AMCR)
The outlook for AMCR is clouded by a conflict between short-term technical momentum and weakening fundamentals. Key catalysts for a re-rating would be a successful reversal of declining revenue trends and improved operational efficiency, particularly through cost-saving initiatives that could expand profit margins. The primary risks are the persistence of these fundamental pressures—declining sales, contracting margins, and poor efficiency—which are especially concerning given the stock's premium valuation, suggesting it is vulnerable to a correction if financial performance does not improve. Without a clear analyst target price, the most probable outcome is a period of consolidation or a pullback toward a more justifiable valuation, with a target range likely below the current price unless the underlying business shows definitive improvement.
Most Wall Street analysts are optimistic about Amcor plc's 12-month outlook, with consensus target around $48.43, indicating expected upside potential.
Overall, AMCR has investment potential but also faces challenges. Here are key factors to weigh before investing.
AMCR has demonstrated strong bullish momentum with significant price appreciation across multiple timeframes. The stock has notably outperformed the broader market, posting double-digit gains over the past three months while exhibiting lower volatility than the overall market based on its Beta below 1.
Over the past month, AMCR has advanced 7.87%, accelerating to a robust 15.41% gain over three months, substantially outperforming the market by 9.78%. This impressive short-term performance indicates strong buying interest and positive momentum despite the stock's typically lower volatility profile.
Currently trading at $48.24, AMCR sits in the upper portion of its 52-week range ($38.33-$52.25), approximately 68% above its lows. While not yet at overbought extremes, the stock appears to be approaching the higher end of its recent trading range, having recovered significantly from its maximum drawdown of -24% experienced during the past year.
| Period | AMCR Return | S&P 500 |
|---|---|---|
| 1m | +9.6% | -1.4% |
| 3m | +13.9% | +4.1% |
| 6m | +13.0% | +7.5% |
| 1y | -4.3% | +15.4% |
| ytd | +15.2% | +0.4% |
Revenue & Profitability: AMCR experienced a 5.2% quarterly revenue decline to $5.45 billion in Q2 2026, while profitability contracted significantly. The net income margin fell to 3.25% from 4.56% in the prior quarter, primarily driven by a compression in gross margin from 19.6% to 16.4%, indicating pressure on pricing or input costs.
Financial Health: The company maintains moderate leverage with a debt ratio of 45.6%, though the interest coverage ratio of 2.7x suggests limited earnings cushion for debt servicing. Notably, the cash flow to debt ratio is weak at 0.03, reflecting minimal operating cash flow relative to total debt obligations.
Operational Efficiency: Operational metrics show challenges, with a low return on equity of 1.52% and an asset turnover of just 0.15, indicating inefficient use of capital to generate sales. The 121-day operating cycle further points to capital being tied up in working capital for extended periods, constraining overall efficiency.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardBased on the available metrics, AMCR appears to be trading at a premium valuation. The TTM PE ratio of 37.8 and an elevated Forward PE of 27.3 suggest high earnings expectations, while a significantly negative PEG ratio of -0.82 indicates potential concerns about future earnings growth. The high EV/EBITDA of 41.7 further supports this view of a potentially overvalued stock relative to its current profitability.
A comprehensive valuation assessment is limited by the unavailability of industry average data. Without this peer comparison context for the PE, PB, and EV/EBITDA ratios, it is difficult to determine whether AMCR's premium multiples are justified by superior performance or are simply out of line with its sector. The negative PEG ratio remains an isolated but notable red flag concerning its growth-adjusted valuation.
Volatility Risk: AMCR exhibits low volatility risk relative to the broader market, as evidenced by its Beta of 0.668, indicating its price tends to be less volatile. However, investors should be aware of its significant 1-year maximum drawdown of -24.0%, which highlights the potential for substantial peak-to-trough losses during market downturns despite its lower beta.
Other Risks: The stock presents a negligible risk from short-selling pressure, given the reported absence of short interest. While this suggests a lack of negative speculative sentiment, investors should still consider broader market liquidity and industry-specific factors, such as commodity price fluctuations impacting its packaging business, as potential sources of risk.
Neutral/Bearish - AMCR appears overvalued with weak fundamentals despite positive technical momentum. The stock trades at premium valuation multiples (P/E 37.8) while showing revenue declines, margin compression, and poor operational efficiency. While recent price action is strong, the fundamentals don't justify current levels. Suitable for momentum traders only; long-term investors should wait for better entry points or fundamental improvement.
Based on the metrics provided, AMCR appears overvalued. Key valuation ratios—a trailing PE of 37.8 and a forward PE of 27.3—are elevated, suggesting the market prices in significant growth that current fundamentals do not support. This is particularly concerning given the negative PEG ratio of -0.82, weak profitability (net income margin of 3.25%), and low operational efficiency (ROE of 1.52%). Without industry averages for direct comparison, the stock’s high multiples seem unjustified relative to its declining revenue and contracting margins.
Based on the provided information, here are the key risks of holding AMCR stock, ordered by importance:
1. Financial Liquidity Risk: The company's minimal cash flow relative to its debt, evidenced by a very weak cash flow to debt ratio of 0.03, creates a significant risk of financial strain in meeting its debt obligations. 2. Profitability and Margin Compression Risk: Recent quarterly results show a sharp decline in profitability, with net income margin falling to 3.25% primarily due to gross margin compression from 19.6% to 16.4%, indicating vulnerability to input cost pressures or weak pricing power. 3. Operational Inefficiency Risk: Poor operational metrics, including a low return on equity of 1.52% and a very low asset turnover of 0.15, signal fundamental inefficiencies in using company assets and capital to generate profits and sales. 4. Price Correction Risk: Despite low volatility, the stock's strong recent performance has it trading near the top of its 52-week range, increasing its vulnerability to a price correction, especially given its history of a significant 24% maximum drawdown.
Based on the conflicting technical momentum and deteriorating fundamentals, Amcor's (AMCR) forecast to 2026 is one of high uncertainty and elevated risk. A base case target range would be $40-$45, reflecting necessary valuation compression to account for declining revenue and profitability unless a clear turnaround emerges. A bull case of $48-$52 would depend entirely on the successful execution of major cost-saving initiatives and a reversal of the sales decline.
Key growth drivers are limited but would hinge on improved pricing power and cost control to restore margins, a significant reduction in the working capital cycle to free up cash, and potential stabilization in end-market demand. The main assumptions are that input cost pressures persist and that management's strategic initiatives take considerable time to show results.
Given the weakness in cash flow relative to debt and the premium valuation, the forecast carries a high degree of uncertainty and is subject to significant downside risk if operational efficiency does not improve.